The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPG, HIAA and HVA levels in the cerebrospinal fluid.

Acta Neurologica Scandinavica. Supplementum
H PrzuntekP Kraus

Abstract

1. The effectiveness and tolerability of deprenyl as an adjunct in the therapy of parkinsonism was studied in a double-blind trial comprising 30 de novo patients. 2. Two thirds of the cases that could be evaluated showed a statistically significant improvement while on adjuvant deprenyl therapy. 3. The improvements are shown in the replugging test, a subtest of the Motor Performance Test, and on the Columbia University Rating Scale. 4. There is no statistically significant correlation between improvement of motor response and depression. 5. Deprenyl seems to be less effective in patients with low contents of HIAA and HVA in the cerebrospinal fluid.

References

Oct 15, 1977·Lancet·A J LeesM B Youdim
Jan 1, 1978·Journal of Neural Transmission·E CsandaA Csanaky
Jan 1, 1978·Journal of Neural Transmission·M D Yahr
Jan 1, 1981·Neurology·T EislerD B Calne
Jan 1, 1983·Acta Neurologica Scandinavica. Supplementum·W Birkmayer
Jan 1, 1983·Acta Neurologica Scandinavica. Supplementum·F GerstenbrandW Poewe
Jan 1, 1983·Acta Neurologica Scandinavica. Supplementum·J Presthus, A Hajba

❮ Previous
Next ❯

Citations

Feb 1, 1992·The Annals of Pharmacotherapy·D S CollierR W Fincham
Mar 4, 1999·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·H PrzuntekH P Vogel

❮ Previous
Next ❯

Related Concepts

Related Feeds

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.